Velan Capital Investment Management LP — 13F Holdings & Portfolio
CIK 1848809 · latest 13F-HR filed 2026-08-14
Velan Capital Investment Management LP manages $164.2M in 13F-reported U.S. long-equity assets across 53 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are PRAX (18.10%), MPLT (10.76%), STRO (10.36%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 6 new positions, exited 5, added to 20, and trimmed 18.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
SUITE 301
ALPHARETTA, GA 30009
$164.2M
Long-equity book
53
Distinct positions
2026-06-30
Filed 2026-08-14
+6 / −5 / ↑20 / ↓18
vs 2026-03-31
| Name | Title / Status | Ownership | Type |
|---|
Top Adds (vs prior quarter)
- MAPLIGHT THERAPEUTICS INC$7.6M +76.3%
- IMMIX BIOPHARMA INC$4.4M +65.9%
- SUTRO BIOPHARMA INC$4.2M +33.3%
- AVALO THERAPEUTICS INC$3.2M +116.9%
- ANTERIS TECHNOLOGIES GLOBAL$3.0M +77.5%
Top Trims
- EVOMMUNE INC-$4.3M -41.5%
- PROTARA THERAPEUTICS INC-$3.9M -26.4%
- INSPIREMD INC-$3.3M -97.0%
- HERON THERAPEUTICS INC-$3.3M -46.7%
- PRAXIS PRECISION MEDICINES I-$2.7M -8.5%
New Positions
- C4 THERAPEUTICS INC$2.7M
- ADMA BIOLOGICS INC$2.1M
- REIN THERAPEUTICS INC$1.8M
- TECTONIC THERAPEUTIC INC$206.2K
- AN2 THERAPEUTICS INC$193.6K
Exited Positions
- ESPERION THERAPEUTICS INC NE$4.7M
- KAZIA THERAPEUTICS LTD$1.0M
- ARROWHEAD PHARMACEUTICALS IN$407.6K
- DESIGN THERAPEUTICS INC$212.8K
- PMV PHARMACEUTICALS INC$90.5K
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | PRAXIS PRECISION MEDICINES I | PRAX | 74006W207 | $29.7M | 18.10% | 88,781 | SH |
| 2 | MAPLIGHT THERAPEUTICS INC | MPLT | 56565P103 | $17.7M | 10.76% | 492,893 | SH |
| 3 | SUTRO BIOPHARMA INC | STRO | 869367201 | $17.0M | 10.36% | 512,160 | SH |
| 4 | IMMIX BIOPHARMA INC | IMMX | 45258H106 | $11.2M | 6.81% | 1,085,000 | SH |
| 5 | PROTARA THERAPEUTICS INC | TARA | 74365U107 | $10.9M | 6.62% | 2,844,652 | SH |
| 6 | ABIVAX SA | ABVX | 00370M103 | $8.7M | 5.33% | 65,630 | SH |
| 7 | TENAX THERAPEUTICS INC | TENX | 88032L605 | $8.0M | 4.87% | 549,985 | SH |
| 8 | ANTERIS TECHNOLOGIES GLOBAL | AVR | 03675P102 | $6.9M | 4.20% | 700,000 | SH |
| 9 | EDESA BIOTECH INC | EDSA | 27966L306 | $6.7M | 4.10% | 827,500 | SH |
| 10 | AVALO THERAPEUTICS INC | AVTX | 05338F306 | $6.0M | 3.65% | 324,452 | SH |
| 11 | EVOMMUNE INC | EVMN | 30054Y107 | $5.9M | 3.61% | 446,255 | SH |
| 12 | XENCOR INC | XNCR | 98401F105 | $4.1M | 2.50% | 255,000 | SH |
| 13 | REZOLUTE INC | RZLT | 76200L309 | $3.9M | 2.38% | 750,000 | SH |
| 14 | HERON THERAPEUTICS INC | HRTX | 427746102 | $3.7M | 2.28% | 8,753,290 | SH |
| 15 | VERRICA PHARMACEUTICALS INC | VRCA | 92511W207 | $2.9M | 1.76% | 471,559 | SH |
| 16 | C4 THERAPEUTICS INC | CCCC | 12529R107 | $2.7M | 1.62% | 570,000 | SH |
| 17 | EUPRAXIA PHARMACEUTICALS INC | EPRX | 29842P105 | $2.3M | 1.42% | 352,000 | SH |
| 18 | ADMA BIOLOGICS INC | ADMA | 000899104 | $2.1M | 1.27% | 250,000 | SH |
| 19 | REIN THERAPEUTICS INC | RNTX | 00887A204 | $1.8M | 1.08% | 1,700,000 | SH |
| 20 | LYELL IMMUNOPHARMA INC | LYEL | 55083R203 | $1.5M | 0.90% | 105,000 | SH |
| 21 | NASUS PHARMA LTD | NSRX | M7071P109 | $1.3M | 0.77% | 359,390 | SH |
| 22 | PROFOUND MED CORP | PROF | 74319B502 | $1.1M | 0.69% | 170,278 | SH |
| 23 | JASPER THERAPEUTICS INC | JSPR | 471871202 | $1.0M | 0.62% | 2,423,067 | SH |
| 24 | TENAX THERAPEUTICS INC Call | TENX | 88032L605 | $999.6K | 0.61% | 68,700 | SH |
| 25 | PROTAGONIST THERAPEUTICS INC | PTGX | 74366E102 | $453.5K | 0.28% | 3,700 | SH |
| 26 | CYTOMX THERAPEUTICS INC. | CTMX | 23284F105 | $450.0K | 0.27% | 120,000 | SH |
| 27 | NEUMORA THERAPEUTICS INC. | NMRA | 640979100 | $391.0K | 0.24% | 230,000 | SH |
| 28 | NURIX THERAPEUTICS INC | NRIX | 67080M103 | $388.2K | 0.24% | 16,000 | SH |
| 29 | OVID THERAPEUTICS INC | OVID | 690469101 | $349.7K | 0.21% | 130,000 | SH |
| 30 | PRECISION BIOSCIENCES INC | DTIL | 74019P207 | $314.4K | 0.19% | 40,000 | SH |
| 31 | MINERALYS THERAPEUTICS INC | MLYS | 603170101 | $296.8K | 0.18% | 11,000 | SH |
| 32 | MACROGENICS INC | MGNX | 556099109 | $277.2K | 0.17% | 60,000 | SH |
| 33 | CORBUS PHARMACEUTICALS HLDGS | CRBP | 21833P301 | $243.9K | 0.15% | 26,000 | SH |
| 34 | ARTIVA BIOTHERAPEUTICS INC | ARTV | 04317A107 | $242.5K | 0.15% | 25,000 | SH |
| 35 | REPLIMUNE GROUP INC | REPL | 76029N106 | $221.4K | 0.13% | 20,000 | SH |
| 36 | SYNDAX PHARMACEUTICALS INC | SNDX | 87164F105 | $218.6K | 0.13% | 10,000 | SH |
| 37 | IMMUNOME INC | IMNM | 45257U108 | $211.9K | 0.13% | 10,000 | SH |
| 38 | TECTONIC THERAPEUTIC INC | TECX | 878972108 | $206.2K | 0.13% | 6,000 | SH |
| 39 | ROCKET PHARMACEUTICALS INC | RCKT | 77313F106 | $205.2K | 0.12% | 60,000 | SH |
| 40 | KARYOPHARM THERAPEUTICS INC | KPTI | 48576U205 | $195.4K | 0.12% | 20,000 | SH |
| 41 | AN2 THERAPEUTICS INC | ANTX | 037326105 | $193.6K | 0.12% | 40,000 | SH |
| 42 | VIRIDIAN THERAPEUTICS INC | VRDN | 92790C104 | $183.7K | 0.11% | 10,000 | SH |
| 43 | SCYNEXIS INC | SCYX | 811292309 | $162.8K | 0.10% | 40,000 | SH |
| 44 | QUOIN PHARMACEUTICALS LTD | QNRX | 74907L409 | $156.7K | 0.10% | 32,372 | SH |
| 45 | XILIO THERAPEUTICS INC | XLO | 98422T209 | $136.8K | 0.08% | 14,285 | SH |
| 46 | INSPIREMD INC | NSPR | 45779A846 | $103.7K | 0.06% | 148,138 | SH |
| 47 | JASPER THERAPEUTICS INC | JSPR | 471871202 | $103.3K | 0.06% | 245,328 | SH |
| 48 | KALARIS THERAPEUTICS INC | KLRS | 482929106 | $101.8K | 0.06% | 25,000 | SH |
| 49 | LARIMAR THERAPEUTICS INC | LRMR | 517125100 | $100.7K | 0.06% | 33,000 | SH |
| 50 | PROQR THRAPEUTICS N V | PRQR | N71542109 | $83.7K | 0.05% | 45,000 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-06-30 | 2026-08-14 | $164.2M | 53 | 0001848809-26-000003 |
| 2026-03-31 | 2026-05-15 | $159.6M | 50 | 0001848809-26-000002 |
| 2025-12-31 | 2026-02-13 | $172.4M | 48 | 0001848809-26-000001 |
| 2025-09-30 | 2025-11-14 | $106.5M | 51 | 0001848809-25-000008 |